Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021

Tianye Li, Haoxiang Zhang, Mengyi Lian, Qionghua He, Mingwei Lv, Lingyun Zhai, Jianwei Zhou, Kongming Wu, Ming YiJournal of Hematology & Oncology 2025 · DOI

Abstract

The burden of female-specific cancers has increased in recent decades, with significant demographic and regional discrepancies. These findings highlight the urgent need for targeted public health interventions to mitigate the global impact of these cancers.

Introduction

Female-specific cancers—specifically breast, cervical, ovarian, and uterine—account for nearly 40% of all cancer diagnoses in women. While medical technology has advanced, the global burden of these diseases is not distributed equally. This study tracks the 30-year global trajectory of these four major cancers, revealing that while total cases are rising, the drivers and outcomes vary sharply by a region's socioeconomic status.

Methods

The researchers utilized data from the Global Burden of Disease Study 2021 (GBD 2021), covering 204 countries and territories. Key metrics included incident cases, deaths, and Disability-Adjusted Life Years (DALYs). To ensure comparability across different population structures, Age-Standardized Rates (ASRs) were employed. The Estimated Annual Percentage Change (EAPC) was calculated to determine significant trends over the three-decade period. Finally, a comparative risk assessment model linked cancer deaths to risk factors such as high BMI, tobacco use, and dietary risks.

A primary finding of the study is the stark "SDI-split." Breast, uterine, and ovarian cancers tend to increase with economic development, whereas cervical cancer remains a primary burden of lower-income regions.

Trends in incidence, mortality, and DALYs for four female-specific cancers by Socio-Demographic Index (SDI) region from 1990 to 2021.

The SDI Paradox

There is a clear "wealth-health" divide. Breast, ovarian, and uterine cancers show a positive correlation with SDI, likely due to "modern" lifestyle factors like high-calorie diets and sedentary behavior. Conversely, cervical cancer shows a negative correlation, acting as a marker of poverty and lack of access to preventative care.

Specific Cancer Insights

  • Breast Cancer: Remains the dominant threat. In 2021, it accounted for 2.08 million incident cases and 0.66 million deaths globally. While total cases have risen, the age-standardized death rate (ASDR) declined slightly, suggesting improvements in treatment and early detection.
  • Cervical Cancer: Globally, incidence is declining thanks to HPV vaccination and screening. However, Southern Sub-Saharan Africa remains a tragic outlier where incidence, mortality, and DALYs are all still rapidly increasing.
  • Uterine Cancer: This is the fastest-growing of the four, with cases more than doubling since 1990. High BMI is identified as the primary attributable risk factor for uterine cancer mortality.
  • Ovarian Cancer: While rates generally rise with SDI, they begin to decline once a region passes an SDI threshold of approximately 0.7, possibly due to higher oral contraceptive use or better detection in high-income nations.
Global distribution of breast cancer deaths in 2021, highlighting the significant burden in countries like China, India, and the USA.

Risk Attribution

The study linked specific risk factors to cancer mortality. Dietary risks and high alcohol use were significant contributors to breast cancer in high-SDI regions. For cervical cancer, unsafe sex and tobacco use were leading risks. Across the board, high BMI was a dominant factor for ovarian and uterine cancers, highlighting a direct link to the global obesity epidemic.

Conclusion and Future Directions

The findings underscore the urgent need for geographically targeted health policies. While wealthier nations must focus on metabolic health and lifestyle-based interventions to curb the rise of uterine and ovarian cancers, low-income regions require expanded international support for HPV vaccination and screening programs. Addressing data gaps in low-income regions and conducting more granular subtype analyses remain critical for future research.

Summary updated

Abstract

The burden of female-specific cancers has increased in recent decades, with significant demographic and regional discrepancies. These findings highlight the urgent need for targeted public health interventions to mitigate the global impact of these cancers.
BibTeX
@article{li2025global,
  author = {Tianye Li and Haoxiang Zhang and Mengyi Lian and Qionghua He and Mingwei Lv and Lingyun Zhai and Jianwei Zhou and Kongming Wu and Ming Yi},
  title = {{Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021}},
  journal = {Journal of Hematology \& Oncology},
  year = {2025},
  doi = {10.1186/s13045-025-01660-y},
}
Figure